A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors
Clinical trial NCT05216965 · UNKNOWN
Trial details
- NCT number
- NCT05216965
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-11
- Primary completion
- 2025-12-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.